Back to Report Store Home

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

  • Published: Jan-2014
  • Report Code: GBIHC320MR
  • Report Format: pdf

Description

List of Tables

Table 1: Gastrointestinal Therapeutics Market, Irritable Bowel Syndrome, Classification, 2009

Table 2: Gastrointestinal Therapeutics Market, Treatment Recommendations for Irritable Bowel Syndrome, 2009

Table 3: Gastrointestinal Therapeutics Market, Classification of Ulcerative Colitis, 2004

Table 4: Gastrointestinal Therapeutics Market, Diagnosis of Ulcerative Colitis, 2007

Table 5: Gastrointestinal Therapeutics Market, Difference Between Ulcerative Colitis and Crohn’s Disease, 2007

Table 6: Gastrointestinal Therapeutics Market, Treatment Options of Ulcerative Colitis, 2011

Table 7: Gastrointestinal Therapeutics Market, Classification of Crohn’s Disease, 2013

Table 8: Gastrointestinal Therapeutics Market, Percentage of Patients Affected by Symptoms of Crohn’s Disease (%), 2012

Table 9: Gastrointestinal Therapeutics Market, Treatment Options for Crohn’s Disease, 2009

Table 10: Gastrointestinal Therapeutics Market, Global, Pipeline (Discovery), 2013

Table 11: Gastrointestinal Therapeutics Market, Global, Pipeline (Preclinical), 2013

Table 12: Gastrointestinal Therapeutics Market, Global, Pipeline (IND/CTA-filed), 2013

Table 13: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase I), 2013

Table 14: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase II), 2013

Table 15: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase III), 2013

Table 16: Gastrointestinal Therapeutics Market, Global, Pipeline (Pre-Registration), 2013

Table 17: Gastrointestinal Therapeutics Market, Global, Pipeline (Undisclosed), 2012

Table 18: Gastrointestinal Therapeutics Asia-Pacific Markets, Irritable Bowel Syndrome, Market Forecast, 2012–2019

Table 19: Gastrointestinal Therapeutics Market, Asia-Pacific Markets, Ulcerative Colitis, Market Forecast, 2012–2019

Table 20: Gastrointestinal Therapeutics Market, Asia-Pacific Markets, Crohn’s Disease, Market Forecast, 2012–2019

Table 21: Gastrointestinal Therapeutics Market, Australia, Irritable Bowel Syndrome, Market Forecast, 2012–2019

Table 22: Gastrointestinal Therapeutics Market, Australia, Ulcerative Colitis, Market Forecast, 2012–2019

Table 23: Gastrointestinal Therapeutics Market, Australia, Crohn’s Disease, Market Forecast, 2012–2019

Table 24: Gastrointestinal Therapeutics Market, India, Irritable Bowel Syndrome, Market Forecast, 2012–2019

Table 25: Gastrointestinal Therapeutics Market, India, Ulcerative Colitis, Market Forecast, 2012–2019

Table 26: Gastrointestinal Therapeutics Market, India, Crohn’s Disease, Market Forecast, 2012–2019

Table 27: Gastrointestinal Therapeutics Market, China, Irritable Bowel Syndrome, Market Forecast, 2012–2019

Table 28: Gastrointestinal Therapeutics Market, China, Ulcerative Colitis, Market Forecast, 2012–2019

Table 29: Gastrointestinal Therapeutics Market, China, Crohn’s Disease, Market Forecast, 2012–2019

Table 30: Gastrointestinal Therapeutics Market, Japan, Irritable Bowel Syndrome, Market Forecast, 2012–2019

Table 31: Gastrointestinal Therapeutics Market, Japan, Ulcerative Colitis, Market Forecast, 2012–2019

Table 32: Gastrointestinal Therapeutics Market, Japan, Crohn’s Disease, Market Forecast, 2012–2019

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards